Cangrelor Use Since FDA Approval: A Single-Center, Real-World Experience at a Tertiary Care Hospital

Overall, 94 patients underwent coronary angiography with the intent of PCI (of whom 88 received >1 stent or balloon angioplasty) for ST-segment elevation myocardial infarction (STEMI) in 49 patients, non-ST-segment elevation acute coronary syndromes (ACS) in 38, and stable angina in 7.  Single-Center Real-World Experience (n = 100) Pooled CHAMPION Trials[low *] (n = 12,475) Demographic characteristics   Age, yrs 64.0 (55-73) 63.0 (55-71) Female 31 27.6 Medical history   Diabetes mellitus 30 29.3 Prior stroke or transient ischemic attack 6 5.2 History of heart failure 13 8.7 History of peripheral artery disease 11 7.1 Indication for cangrelor use   ST-segment elevation myocardial infarction 49 11.3 Non-ST-segment elevation acute coronary syndrome 38 57.3 Stable angina 7 31.4 Other 6 0 Patient presentation   Cardiogenic shock 16 --